Search research articles
Contact Us
Filters
Showing results (81-90 of 129) with videos related to
Page
of 13
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
December 28, 2019
CCR2 inhibition reduces tumor myeloid cells and unmasks a checkpoint inhibitor effect to slow progression of resistant murine gliomas
Joseph A Flores-Toro, Defang Luo, Adithya Gopinath, et al.
Plos One
|
March 26, 2013
Myeloablative temozolomide enhances CD8⁺ T-cell responses to vaccine and is required for efficacy against brain tumors in mice
Luis A Sanchez-Perez, Bryan D Choi, Gary E Archer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 26, 2015
Differential Immune Microenvironments and Response to Immune Checkpoint Blockade among Molecular Subtypes of Murine Medulloblastoma
Christina D Pham, Catherine Flores, Changlin Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 14, 2020
Immune Escape After Adoptive T-cell Therapy for Malignant Gliomas
Tyler J Wildes, Kyle A Dyson, Connor Francis, et al.
Neuro-Oncology
|
December 15, 2007
Immunological responses in a patient with glioblastoma multiforme treated with sequential courses of temozolomide and immunotherapy: case study
Amy B Heimberger, Wei Sun, S Farzana Hussain, et al.
Frontiers in Molecular Neuroscience
|
April 13, 2018
The IDH1 Mutation-Induced Oncometabolite, 2-Hydroxyglutarate, May Affect DNA Methylation and Expression of PD-L1 in Gliomas
Luyan Mu, Yu Long, Changlin Yang, et al.
Genome Medicine
|
January 24, 2024
mRNA-based precision targeting of neoantigens and tumor-associated antigens in malignant brain tumors
Vrunda Trivedi, Changlin Yang, Kelena Klippel, et al.
Journal of Neuro-Oncology
|
October 7, 2023
Patterns and predictors of anxiety and depression symptom trajectories in patients diagnosed with primary brain tumors
Alayna E Ernster, Anjelica Body, Phuong Deleyrolle, et al.
Cancer Immunology, Immunotherapy : CII
|
April 18, 2013
BLyS levels correlate with vaccine-induced antibody titers in patients with glioblastoma lymphodepleted by therapeutic temozolomide
Luis Sanchez-Perez, Bryan D Choi, Elizabeth A Reap, et al.
Molecular Cancer Therapeutics
|
October 15, 2009
An epidermal growth factor receptor variant III-targeted vaccine is safe and immunogenic in patients with glioblastoma multiforme
John H Sampson, Gary E Archer, Duane A Mitchell, et al.
Page
of 13
Search research articles
Search
Showing results (81-90 of 129) with videos related to
Sort By:
Page
of 13
Proceedings of the National Academy of Sciences of the United States of America
|
December 28, 2019
CCR2 inhibition reduces tumor myeloid cells and unmasks a checkpoint inhibitor effect to slow progression of resistant murine gliomas
Joseph A Flores-Toro, Defang Luo, Adithya Gopinath, et al.
Plos One
|
March 26, 2013
Myeloablative temozolomide enhances CD8⁺ T-cell responses to vaccine and is required for efficacy against brain tumors in mice
Luis A Sanchez-Perez, Bryan D Choi, Gary E Archer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 26, 2015
Differential Immune Microenvironments and Response to Immune Checkpoint Blockade among Molecular Subtypes of Murine Medulloblastoma
Christina D Pham, Catherine Flores, Changlin Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 14, 2020
Immune Escape After Adoptive T-cell Therapy for Malignant Gliomas
Tyler J Wildes, Kyle A Dyson, Connor Francis, et al.
Neuro-Oncology
|
December 15, 2007
Immunological responses in a patient with glioblastoma multiforme treated with sequential courses of temozolomide and immunotherapy: case study
Amy B Heimberger, Wei Sun, S Farzana Hussain, et al.
Frontiers in Molecular Neuroscience
|
April 13, 2018
The IDH1 Mutation-Induced Oncometabolite, 2-Hydroxyglutarate, May Affect DNA Methylation and Expression of PD-L1 in Gliomas
Luyan Mu, Yu Long, Changlin Yang, et al.
Genome Medicine
|
January 24, 2024
mRNA-based precision targeting of neoantigens and tumor-associated antigens in malignant brain tumors
Vrunda Trivedi, Changlin Yang, Kelena Klippel, et al.
Journal of Neuro-Oncology
|
October 7, 2023
Patterns and predictors of anxiety and depression symptom trajectories in patients diagnosed with primary brain tumors
Alayna E Ernster, Anjelica Body, Phuong Deleyrolle, et al.
Cancer Immunology, Immunotherapy : CII
|
April 18, 2013
BLyS levels correlate with vaccine-induced antibody titers in patients with glioblastoma lymphodepleted by therapeutic temozolomide
Luis Sanchez-Perez, Bryan D Choi, Elizabeth A Reap, et al.
Molecular Cancer Therapeutics
|
October 15, 2009
An epidermal growth factor receptor variant III-targeted vaccine is safe and immunogenic in patients with glioblastoma multiforme
John H Sampson, Gary E Archer, Duane A Mitchell, et al.
Page
of 13